DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20190007

Adenoidectomy versus mometasone furoate nasal spray in treatment of nasal obstruction in children due to adenoid hypertrophy: a comparative study

Vishwas K. Pai, Shravan S. Shetty, P. P. Devan, S. G. Mahesh

Abstract


Background: One of the common causes for nasal obstruction in children is adenoid hypertrophy. It is common indication for surgical removal in these patients due to multiple morbidities. In severe symptoms adenoidectomy is recommended, however there are limitations for surgery like cleft palate.The safety of nasal steroid spray has been well reported. The aim of the current study is to determine the effectiveness of adenoidectomy verses mometasone nasal spray in treatment of children with adenoid hypertrophy.

Methods: Randomized prospective study was conducted in the department of ENT on 60 children who met the inclusion criteria. They were randomized into 2 groups and pre-treatment scoring was accessed. Group A underwent adenoidectomy and Group B underwent mometasonefuroate nasal spray therapy. Patients were evaluated on 40th day, 4th month.  

Results: During the 40th day follow up post treatment, a significant difference was found with no nasal obstruction in 93.3% patients who underwent adenoidectomy compared to 63.3% for those treated with MF nasal. At follow up after 4 months, 93.3% patients in group A had had improvement in clinically as compared to 76.6% in group B were nasal obstruction was relived. In group A, there was significant reduction in adenoid grading after adenoidectomy compared to MF nasal spray at 40 days follow up (p≤0.001). However long term MF nasal spray also associated with significant reduction in the size.

Conclusions: In patients were adenoidectomy is contraindicated, long term MF nasal spray treatment has good efficacy in treatment of nasal obstruction due to adenoid hypertrophy.


Keywords


Adenoid hypertrophy, Adenoidectomy, Mometasonefuroate nasal spray, Nasal obstruction

Full Text:

PDF

References


Rutkow IM. Ear, nose, and throat operations in the United States, 1979 to 1984. Arch Otolaryngol-Head Neck Surg. 1986;112(8):873-6.

Scadding G. Non-surgical treatment of adenoidal hypertrophy, The role of treating IgE mediated inflammation. Pediatric Allergy Immunol. 2010;21(8):1095-106.

Grundfast KM, Wittich DJ Jr. Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective. The Latyngoscope. 1982;92(6):650-6.

Potsic WP, Wetmore RF. Sleep disorders and airway obstruction in children. Otolaryngologic Clin North Am. 1990;23(4):651-63.

Gates GA, Muntz HR, Gaylis B. Adenoidectomy and otitis media. Ann Otol Rhinol Laryngol. 1992;155:24-32.

Stuck BA, Windfuhr JP, Genzwurker H, Schroten H, Tenenbaum T, Gotte K. Tonsillectomy in Children. Deutsches Arzteblatt Int. 2008;105(49):852-61.

Berlucchi M, Valetti L, Parrinello G, Nicolai P. Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. Int J Pediatric Otorhinolaryngol. 2008;72(8):1171-5.

Nayak AS. Ellis MM, Gross GN, Mendelson LM, Sohenkel EJ, Lanier BQ, Simpson B, Mullin ME. Smith JA. The effects of triamcinolone acetomideacqueous nasal spray on the adrenocortical function in children with allergic rhinitis. J Allergy Clinic Immunol. 1988;101:157-62.

Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once daily mometasonefuroate aqueous nasal spray in children. Clin Therap. 1997;19(6):1330 -7.

Paulussen C, Claes J, Claes G, Jorissen M. Adenoids and tonsils, indications for surgery and immunological consequences of surgery. Acta Otorhinolaryngol Belg. 2000;54:403-8.

Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclamethasone. Pediatrics. 1995;95:355-64.

Gupta V, Gupta M, Matreja PS, Singh S. Efficacy of mometasone nasal spray in children with snoring due to Adenoids. Clin Rhino An int J. 2014;7(1):1-4.

Rezende RM, Silveira F, Barbosa AP, Menezes UP, Ferriani VP, Rezende PH, et al. Objective reduction in adenoid tissue after mometasone furoate treatment. Int J Pediatr Otorhinolaryngol. 2012;76(6):829-31.